| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TransMedics Group, Inc. | Chief Commercial Officer | Common Stock | 19,057 | $2,648,351 | $138.97 | 18 Feb 2026 | Direct |
| TransMedics Group, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 16,734 | 18 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TMDX | TransMedics Group, Inc. | 18 Feb 2026 | 2 | $0 | 4 | Chief Commercial Officer | 20 Feb 2026, 16:07 |
| TMDX | TransMedics Group, Inc. | 02 Feb 2026 | 0 | $0 | 3 | Chief Commercial Officer | 12 Feb 2026, 16:15 |
| TMDX | TransMedics Group, Inc. | 14 Mar 2025 | 0 | $0 | 3/A | Chief Commercial Officer | 20 Feb 2026, 16:05 |